Tamoxifen (Nolvadex) Research in Pennsylvania | QSC

Tamoxifen (Nolvadex) Research — Pennsylvania

Tamoxifen (Nolvadex) is a Selective Oestrogen Receptor Modulator (SERM) used in research models studying Breast Cancer / ER-positive Tumour Research, Gynecomastia Research, HPG Axis / PCT Research. QSC supplies Tamoxifen to research institutions, university laboratories, and independent researchers across Pennsylvania with domestic USA shipping and third-party Janoshik COA verification.

About Tamoxifen (Nolvadex)

Tamoxifen is a triphenylethylene SERM. Competitively binds oestrogen receptor alpha (ERα) with high affinity. Tissue-selective: acts as ER antagonist in breast tissue (blocking oestrogen-driven proliferation) but as partial ER agonist in bone and uterus. Metabolised by CYP2D6 to the active 4-hydroxytamoxifen and endoxifen, which have 30–100× higher ERα affinity than tamoxifen itself. Also used in …

Full mechanistic overview and research data: Tamoxifen Research Hub →

QSC Shipping to Pennsylvania

QSC operates a domestic USA fulfilment network with 5-region shipping coverage. Orders to Pennsylvania ship from the nearest domestic hub — typically 3–5 business days. All compounds ship in sealed, temperature-appropriate, discrete packaging with Janoshik COA documentation.